Semaglutide directly improves mitochondrial function in insulin-resistant muscle cells independent of weight loss | Research

The takeaway

In an insulin-resistant myotube model, semaglutide directly improved mitochondrial respiration and insulin sensitivity through GLP-1 receptor activation, demonstrating metabolic benefits independent of weight loss.

Direct mitochondrial improvement
Semaglutide enhanced mitochondrial function and insulin sensitivity in muscle cells independently of weight loss—proving direct cellular metabolic effects

What the researchers found

Semaglutide directly activated GLP-1R on myotubes. Improved mitochondrial respiration in insulin-resistant cells. Enhanced insulin-stimulated glucose uptake. Effects independent of weight loss (cell culture model).

Why it matters

The debate about whether GLP-1 drugs benefit metabolically through weight loss alone or have direct cellular effects is critical. This study proves direct muscle cell benefits, suggesting GLP-1 drugs improve metabolism even before significant weight is lost.

How the study worked

In vitro insulin-resistant myotube model. Semaglutide treatment. GLP-1R expression and activation. Mitochondrial respiration (Seahorse). Insulin-stimulated glucose uptake.

What this study cannot tell us

In vitro cell model—cannot capture whole-body physiology. Myotube model may not fully represent mature skeletal muscle. Dose may not reflect clinical exposure. Long-term effects unknown.

How to read the evidence

In vitro mechanistic study. Clear demonstration of direct cellular effects but limited by cell culture context.

When this study was published

Published in 2025.

The bigger picture

This supports semaglutide as a true metabolic drug, not just a weight loss drug. Direct improvements in mitochondrial function and insulin sensitivity mean metabolic benefits begin at the cellular level before scale weight changes.

Questions still open

Do these direct mitochondrial effects occur in human muscle in vivo?
Could GLP-1 drugs benefit non-obese insulin-resistant patients through these mechanisms?
Do different GLP-1 agonists differ in direct muscle effects?

Common questions

Does semaglutide only work through weight loss?

No. This study proved semaglutide directly improves how muscle cells produce energy (mitochondrial function) and respond to insulin, completely independent of any weight loss effect. This means metabolic benefits start at the cellular level even before you see changes on the scale.

What does improved mitochondrial function mean?

Mitochondria are the energy factories in every cell. In diabetes and insulin resistance, mitochondria work poorly, contributing to metabolic dysfunction. Semaglutide directly improved mitochondrial performance in muscle cells, meaning cells can produce energy more efficiently and handle blood sugar better.

Read the original research

The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance.

Molecular and cellular endocrinology, 608, 112629

View on PubMed ↗Publisher’s paper ↗

Citation

Spry, Emmalie R; Travis, Kipton B; Ragland, Kayla J; Klein, Alexa J; Zimmerman, John M; Vaughan, Roger A. (2025). The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance.. Molecular and cellular endocrinology, 608, 112629. https://doi.org/10.1016/j.mce.2025.112629